Deacetyl vinorelbine

CAS : 126347-74-8

Ref. 3D-FD20831

Informations sur le produit

• Nom: Deacetyl vinorelbine
• Synonymes: O4-Deacetyl-3',4'-didehydro-4'-deoxy-C'-norvincaleukoblastineDesacetylnavelbineO-Deacetylnavelbine, C'-Norvincaleukoblastine, O4-deacetyl-3',4'-didehydro-4'-deoxy-, methyl (2beta,3beta,4beta,5alpha,19alpha)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate, Desacetylnavelbine

Description

Deacetyl vinorelbine is a prodrug that is metabolized to its active form, vinorelbine. It is used in the treatment of cancer and lung cancer. Deacetyl vinorelbine is converted by hydrolysis to deacetylvinorelbine, which inhibits the enzyme topoisomerase II and blocks DNA synthesis, leading to cell death. Vinorelbine also inhibits cellular respiration by inhibiting mitochondrial cytochrome c oxidase and blocking electron transfer from cytochrome c to oxygen. The drug binds to human serum albumin with high affinity and has been shown to have a long half-life in humans due to its ability to bind tightly with proteins such as serum albumin. This binding prevents the drug from being eliminated through the kidneys or liver, prolonging its activity in the body.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 736.9 g/mol
• Formule: C₄₃H₅₂N₄O₇
• Degré de pureté: Min. 95%
• Couleur/Forme: Solid